|
000
| 02826cam 2200469zi 4500 |
|---|
| 001 | 9.925315 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230908110745 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 230721t20232023onco o f000 0 eng d |
|---|
| 020 | |a9780660495934 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-447/2023E-PDF |
|---|
| 245 | 00|aPre- and post-campaign ACET for stigma and opioid harm reduction advertising campaign : |bmethodological report / |cprepared for Health Canada. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2023. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (23 pages) : |bphotographs + |e1 executive summary (3 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"May 2023." |
|---|
| 500 | |a"Supplier name: Ipsos Public Affairs." |
|---|
| 500 | |a"Contract Number: CW2235438." |
|---|
| 500 | |a"Registration number: POR 012-22." |
|---|
| 500 | |aIssued also in French under title: OECP avant et après la campagne publicitaire sur la réduction de la stigmatisation et des méfaits liés aux opioïdes : rapport méthodologique. |
|---|
| 520 | |a"Responding to the opioid overdose crisis is a 2021 mandate commitment for the Minister of Health, who has been tasked with advancing a comprehensive strategy to address problematic substance use in Canada and support efforts to improve public education to reduce stigma. As part of that commitment, a campaign was launched that focused on reducing the barriers created by stigma such as seeking treatment"--Background, page 1. |
|---|
| 650 | 0|aOpioid abuse|zCanada|xPrevention|xPublic opinion. |
|---|
| 650 | 0|aStigma (Social psychology)|zCanada|xPublic opinion. |
|---|
| 650 | 0|aAdvertising campaigns|zCanada|xPublic opinion. |
|---|
| 650 | 0|aGovernment advertising|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aIpsos (Firm). |bPublic Affairs, |econsultant. |
|---|
| 775 | 08|tOECP avant et après la campagne publicitaire sur la réduction de la stigmatisation et des méfaits liés aux opioïdes : |w(CaOODSP)9.925316 |
|---|
| 856 | 40|qPDF|s690 KB|uhttps://publications.gc.ca/collections/collection_2023/sc-hc/H14-447-2023-eng.pdf|zMethodological report |
|---|
| 856 | 40|qPDF|s315 KB|uhttps://publications.gc.ca/collections/collection_2023/sc-hc/H14-447-2023-1-eng.pdf|zExecutive summary |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2023/012-22-e/012_22_Report_EN.html|zMethodological report |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2023/012-22-e/summary/012_22_ES_EN.html|zExecutive summary |
|---|